Latest Diabetes: Type II news
Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
posted May 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
SGLT2 Inhibitors Reduce Heart Failure Hospitalization
Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes
posted May 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Skyrizi Approved for Psoriatic Arthritis
Early Glycemic Control May Cut CV Risk in Type 2 Diabetes
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Add-On PPI Therapy May Improve Glycemic Control in Diabetes
Using New Guidelines Would Increase Diabetes Screening Eligibility
posted May 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Anti-SSA, Anti-SSB Antibodies Low in RA Patients Wishing to Conceive
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Related Articles
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Monthly Specialist Briefings
Stay Connected
